GlassScriptPhysician profile
Mason Miller
NPI 1215534599
$951.43
in general payments reported to CMS, 2019-2025
11 companies · $625 in 2025
The $625 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.88 · 2022: $67.00 · 2023: $102 · 2024: $139 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $486 · Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $485.99 |
| Food and Beverage | $380.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $625.32 | 2025 | Vasoview Hemopro 2, Acrobat-I Stabilizer |
| Haemonetics Corporation | $105.96 | 2024 | Teg6s Hemostasis System |
| Medtronic, INC. | $44.61 | 2022-2024 | Endurant Iis, Penditure |
| Lemaitre Vascular, INC. | $33.34 | 2022 | |
| Kci USA, INC. | $23.59 | 2023 | V.A.C. Veraflo Cleanse Choice |
| Boston Scientific Corporation | $21.73 | 2023 | Interlock |
| Teleflex LLC | $21.27 | 2022 | |
| Stryker Corporation | $21.14 | 2023 | Spy-Phi System |
| Silk Road Medical, INC. | $18.87 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Terumo Medical Corporation | $17.88 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $17.72 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mason Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.